Overview

Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This is a phase 2 study of gemcitabine + high-dose chemotherapy followed by peripheral blood stem cell (PBSC) rescue for Hodgkin's Disease
Phase:
Phase 2
Details
Lead Sponsor:
Stanford University
Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID)
National Institutes of Health (NIH)
Treatments:
Carmustine
Cyclophosphamide
Etoposide
Gemcitabine
Vinorelbine